Firm

Xiaoyan Zhou of Purplevine IP explains how to protect IP in the rapidly developing area of AI medical devices in China, and the risks involved

David Herman of FB Rice explains what steps are involved in interpreting New Zealand’s Patents Act 2013 and summarises several significant rulings that have established precedents in patent law

Sumin Lai of Saint Island International Patent & Law examines the IP and Commercial Court v ordinary courts to exercise jurisdiction over civil actions from IP rights in Taiwan

Roman Brtka of Bird & Bird comments on the Ferrari Front Kit case and explains the practical consequences for manufacturers that want to protect a part of a product independently of the whole product

Join Ude Lu, the chief IP counsel (US) of Purplevine IP, Helen Zhang, the litigation manager of Purplevine IP in Beijing, and Penny Sun, the brand protection manager of ABRO Industry, as they discuss evidence collection for patent enforcement in China and the US virtually with Managing IP on November 9 at 10am (US ET) / 3pm (UK) / 11pm (China)

Jaime Rodríguez of Olivares explains the implications of the revocation by the Mexican Federal Court of Administrative Affairs of the criteria commonly used to allow complainants to credit their legal standing on trademark non-use cancellation proceedings